Loading cancer entity…
Loading cancer entity…
Clinical trials
26 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT07560332 | Oral Propranolol Versus Fractional Carbon Dioxide CO2 Laser Assisted Delivery of Topical Timolol for Treatment of Infantile Hemangioma | completed | N/A | 30 | Cairo UniversityOTHER | 1 | May 1, 2026 | clinicaltrials |
| NCT00975819 | Safety and Efficacy Study of Sirolimus in Complicated Vascular Anomalies | completed | Phase 2 | 61 | Denise Martin AdamsOTHER | 1 | Jan 6, 2026 | clinicaltrials |
| NCT07104526 | Low-Dose Propranolol and Bleomycin for Infantile Hemangioma (IH) | completed | N/A | 260 | Wuhan Integrated Traditional Chinese and Western Medicine HospitalOTHER | 1 | Aug 5, 2025 | clinicaltrials |
| NCT06677853 | Timolol Maleate Gel for the Treatment of Infantile Hemangioma |
Data updated 22 days agoSource updated May 1, 2026source: clinicaltrials
| completed |
| Phase 2 / Phase 3 |
| 168 |
| Auson Pharmaceuticals Inc.INDUSTRY |
| 1 |
| Nov 7, 2024 |
| clinicaltrials |
| NCT02913612 | Efficacy, Safety and Pharmacokinetics of Topical Timolol in Infants With Infantile Hemangioma (IH)(TIM01) | completed | Phase 2 | 105 | Kanecia Obie ZimmermanOTHER | 1 | Mar 12, 2024 | clinicaltrials |
| NCT01431326 | Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care(PTN_POPS) | completed | — | 3,520 | Daniel BenjaminOTHER | 5 | Sep 6, 2023 | clinicaltrials |
| NCT05080868 | Infantile Hemangioma With Minimal or Arrested Growth : Epidemiology, Clinical Characteristics and Evolution | completed | — | 224 | Central Hospital, Nancy, FranceOTHER | 1 | Oct 18, 2021 | clinicaltrials |
| NCT01010308 | Nadolol for Proliferating Infantile Hemangiomas | completed | Phase 2 | 20 | The Hospital for Sick ChildrenOTHER | 1 | Aug 19, 2021 | clinicaltrials |
| NCT04105517 | Hemangiol, Post Marketing Surveillance Study(postHemangiol) | completed | — | 500 | University Hospital, MontpellierOTHER | 1 | Dec 2, 2020 | clinicaltrials |
| NCT02505971 | Nadolol Versus Propranolol in Children With Infantile Hemangiomas | completed | Phase 3 | 74 | The Hospital for Sick ChildrenOTHER | 1 | Oct 28, 2020 | clinicaltrials |
| NCT01673971 | Optical Tomographic Imaging of Infantile Hemangiomas | completed | — | 15 | Columbia UniversityOTHER | 1 | Aug 6, 2018 | clinicaltrials |
| NCT01056341 | Study to Demonstrate the Efficacy and Safety of Propranolol Oral Solution in Infants With Proliferating Infantile Hemangiomas Requiring Systemic Therapy | completed | Phase 2 / Phase 3 | 512 | Pierre Fabre DermatologyINDUSTRY | 16 | Dec 10, 2015 | clinicaltrials |
| NCT01512173 | Study in Infants With Infantile Hemangioma to Compare Propranolol Gel to Placebo | completed | Phase 2 | 82 | Pierre Fabre DermatologyINDUSTRY | 3 | Oct 30, 2014 | clinicaltrials |
| NCT00601016 | A Phase II Study of Imiquimod 5 % Cream for the Treatment of Hemangioma in Infancy | completed | Phase 2 | 18 | St. Justine's HospitalOTHER | 1 | Jan 25, 2008 | clinicaltrials |